By studying how the cancers and different progenitors, such as the oviductal or OSE, respond to estrogen may aid in the use of SERMs in tumors that express ER or help to uncover if long-term use of Tamoxifen could enhance dysplastic lesions in the fallopian tube. The gene discussed is ESR1; the disease is cancer.